Navigation Links
Biotherapeutic Innovations on Display at AAPS National Biotechnology Conference

ARLINGTON, VA (May 11, 2010) Advancement in the treatment of cocaine overdoses and a new defense in the fight against HIV are just two examples of the groundbreaking research that will be unveiled at the American Association of Pharmaceutical Scientists' (AAPS) National Biotechnology Conference (NBC). The conference takes place Sunday, May 16 -Thursday, May 20 at the Hilton San Francisco Union Square in San Francisco, Calif.

A Possible Treatment for Cocaine Addiction

Researchers from the University of Kentucky have discovered high-activity mutants of human butyrylcholinesterase (BChE) that have potential value in the development of anti-cocaine medication. The ideal treatment accelerates cocaine metabolism by producing biologically inactive metabolites via a route similar to the primary cocaine-metabolizing pathway.

"Cocaine addiction and overdose are well-known public health problems; there is no FDA (Food and Drug Administration)-approved medication specifically for cocaine abuse treatment," said Chang-Guo Zhan, Ph.D., research team leader and professor of pharmaceutical sciences at Kentucky. "In this research, we aim to design and discover an efficient cocaine hydrolase, which can be used for therapeutic treatment of cocaine overdose, and we have discovered one by engineering BChE."

The design has been successfully tested in mice. Zhan will present this research during the Sunrise Session on "Computational Approaches to Protein Drug Discovery and Development," from 7 a.m. to 8 a.m. on Tuesday, May 18, and at the Roundtable Session on "Rational Design of Protein Drug Stabilization," from 10:30 a.m. to 12:00 p.m. on Wednesday, May 19.

Developing Countries See Hope in the Battle against HIV

The possibility for a microbiocide-based HIV prevention measure holds particular promise for developing countries, particularly in sub-Saharan Africa, where the number of people living with HIV, as of 2008, was 22.4 million according to a report by the Joint United Nations Programme on HIV/AIDS and the World Health Organization . Microbiocides gives women, particularly in patriarchal societies, a level of confidence and control when it comes to contraception use; this particular microbiocide would be a dissolving film as opposed to microbiocides that require a plastic applicator, which makes for more discreet usage and less waste.

These studies and other novel research will be presented during a week of educational programming devoted to advancing health through biotherapeutics. Conference programming consists of a Plenary Session, symposia, roundtables, posters, hot topics, and concludes with two short courses. Additionally, the Exposition Hall will be hosting over 100 companies.


Contact: Joseph Catapano
American Association of Pharmaceutical Scientists

Related biology news :

1. Leaders from the National Academies gather to discuss engineering innovations in health care
2. MIT student develops new innovations to selectively kill cancer cells
3. New research program for energy innovations
4. Innovations in Pediatric Medicine International Conference brings together pediatrics experts
5. Innovations in Pediatric Medicine CME conference brings together national pediatrics experts
6. Improving industry efficiency through environmental innovations
7. New chemical radar among national security innovations in ACS podcast
8. Sonic Innovations Celebrates 10-Year Anniversary
9. Synaptics SecurePad(TM) Selected as CES Innovations 2008 Design and Engineering Award Honoree
10. OHSU turns innovations into commercial opportunities at record pace
11. Touch the Earth to display at Earth Day on National Mall
Post Your Comments:
(Date:10/29/2015)... NXTD ) ("NXT-ID" or ... the growing mobile commerce market and creator of ... leading marketplace to discover and buy innovative technology ... on StackSocial for this holiday season.   ... a biometric authentication company focused on the growing ...
(Date:10/27/2015)... , Oct. 27, 2015 Synaptics Inc. (NASDAQ: ... announced that Google has adopted the Synaptics ® ... solutions to power its newest flagship smartphones, the Nexus ... --> --> ... to provide strategic collaboration in the joint development of ...
(Date:10/23/2015)... 23, 2015 Research and Markets ( ... Voice Recognition Biometrics Market 2015-2019" report to their ... The global voice recognition biometrics market to grow ... --> --> The report, ... based on an in-depth market analysis with inputs from ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... November 25, 2015 Studies reveal ... human plaque and pave the way for more effective treatment ... cats     --> ... diagnosed health problems in cats, yet relatively little was understood ... collaborative studies have been conducted by researchers from the WALTHAM ...
(Date:11/25/2015)... Nov. 25, 2015 Orexigen® Therapeutics, Inc. (Nasdaq: ... in a fireside chat discussion at the Piper Jaffray ... . The discussion is scheduled for Wednesday, December ... .  A replay will be available for 14 ... , Julie NormartVP, Corporate Communications and Business Development ...
(Date:11/24/2015)... -- Cepheid (NASDAQ: CPHD ) today announced that ... and invited investors to participate via webcast. ... 1, 2015 at 11.00 a.m. Eastern Time --> ... 1, 2015 at 11.00 a.m. Eastern Time --> ... NY      Tuesday, December 1, 2015 at 11.00 ...
(Date:11/24/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) (the ... the Toronto Stock Exchange, confirms that as of the ... developments that would cause the recent movements in the ... --> About Aeterna Zentaris Inc. ... Aeterna Zentaris is a specialty biopharmaceutical company engaged in ...
Breaking Biology Technology: